THE SCIENCE BENEATH THE SYSTEM

Established interventions.
Intelligently combined.

Rejuvie is not attempting to invent new sleep physiology. It combines established interventions across darkness, noise control, audio and timed light in one adaptive system designed for all-night use.

01

Sleep onset

20–60%

estimated faster sleep onset

For users in sub-optimal sleep environments

Basis for the estimate

Published evidence supports light control, noise attenuation and selected audio interventions as ways to reduce sleep-onset difficulty. Synthesising reported intervention effects with sleep-onset latencies commonly seen in disturbed environments gives an estimated reduction of approximately 10–30 minutes, or roughly 20–60%.

Important limitation

The effect will depend heavily on the user, their baseline sleep latency and the source of disruption. This is a modelled range from constituent-intervention research, not a measured Rejuvie result.

02

Sleep continuity and quality

25–40%

estimated improvement in sleep quality

Where noise and light are materially disrupting sleep

Basis for the estimate

A clinical review of noise-reduction strategies reported average sleep improvements of 25.3% for earplugs and 42.7% for sound masking in intensive-care research. Rejuvie combines blackout, passive and active noise control, sound masking and adaptive audio; 25–40% is therefore used as a rounded, conservative estimate for disrupted settings.

Important limitation

The underlying studies use different populations, interventions and sleep measures, so these figures should not be treated as a pooled clinical effect. The likely benefit is smaller in an already quiet, dark, optimised bedroom.

03

Wake-up

Wake

with greater alertness

Using timed light before and around the point of waking

Basis for the estimate

Small randomised studies suggest that dawn-simulation light delivered before waking can improve subjective alertness and selected measures of post-waking performance. In one crossover study, reaction time improved from 0.86 to 0.81 seconds, alongside higher alertness and better performance on an addition task.

Important limitation

Evidence is promising but mixed, sample sizes are small and protocols vary. Rejuvie must still demonstrate that its light system delivers a sufficient, safe and repeatable circadian-relevant dose through the closed eyelid.

WHAT REJUVIE WILL VALIDATE

The complete system, not just its parts.

01

Comfort, fit and adherence across a full night

02

Measured effects on sleep onset, continuity and morning alertness

03

Light dose, safety and between-user variability at the eye

04

Which interventions work best for which users and environments